IP Verse

Dosage Regimes For The Administration Of Glucagon-Like-Peptide-2 (Glp-2) Analogues

Patent No. EP3881861 (titled "Dosage Regimes For The Administration Of Glucagon-Like-Peptide-2 (Glp-2) Analogues") was filed by Zealand Pharma on Jun 15, 2018. The application was issued on Jul 31, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
IRONWOOD PHARMACEUTICALSApr 29, 2025COHAUSZ & FLORACK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3881861

ZEALAND PHARMA
Application Number
EP21150552A
Filing Date
Jun 15, 2018
Status
Granted And Under Opposition
Jun 27, 2024
Publication Date
Jul 31, 2024
External Links
Slate, Register , Google Patents